Skip to main content
Clinical Trials/IRCT20210807052098N1
IRCT20210807052098N1
Not yet recruiting
Phase 4

Investigation of intravenous dexmedetomidine administration effect on patency of arteriovenous fistula in patients undergoing arteriovenous fistula creation surgery

Ghoum University of Medical Sciences0 sites50 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Condition 1: renal failure. Condition 2: dexmedetomidine. Condition 3: arteriovenous fistula.
Sponsor
Ghoum University of Medical Sciences
Enrollment
50
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ghoum University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • patients with renal failure and dependent on dialysis
  • candidate for arteriovenous fistula surgery
  • without heart failure
  • age below eighty years

Exclusion Criteria

  • The patient's unwillingness to participate in the study at any time during the study
  • Contraindications for the use of dexmedetomidine: severe heart block, severe bradycardia, severe heart failure, QT changes, hypotension, liver failure, intravascular volume depletion, allergy to alpha 2 agonists
  • age over 80 years
  • heart failure

Outcomes

Primary Outcomes

Not specified

Similar Trials